InvestorsHub Logo
Post# of 253152
Next 10
Followers 125
Posts 21098
Boards Moderated 0
Alias Born 06/13/2011

Re: DewDiligence post# 213166

Wednesday, 08/16/2017 7:00:17 PM

Wednesday, August 16, 2017 7:00:17 PM

Post# of 253152
MYOK Thx Dew ..I've owned it from $7.50 ..increasing my position over time .
Co is based in the Bay Area ( where I reside ) and I'm fortunate to know some one ( Stanford PHD ) who is familiar with top management .
I'm also a CAD ( coronary artery disease ) patient with a thickening of the walls of my left ventricle ...so I follow the Co's research.

IMHO this Co will apply for a Break Through Therapy designation . They will meet with the FDA before Oct 10th to discuss the P 2 results and hopefully finalize design of their pivotal trial scheduled late this year , early 2018

There will also be an important readout out on their second candidate MYK491 ...dilated cardiomyopathy ( DCM ) in which there is a serious unmet need and no approved therapies ...in this Qt of 2017 ..its a P1 trial .

There are risks ...will FDA allow them to proceed directly into a pivotal trial or want a P2 b trial run first ( my lay mans take ) ?.....but I suggest those that follow your board, chk the Co out .

Kiwi
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.